TELA Bio, Inc. (TELA) Current Ratio
- Current ratio · latest quarter: Value 2.99×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.99× | Current assets / current liabilities. $54.49M ÷ $18.22M ≈ 2.99× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 54.49M USD | Assets, Current |
| Current obligations | 18.22M USD | Liabilities, Current |
| Cash and equivalents | 30.42M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | 11.06M USD | Inventory, Net |
| Payables | 2.88M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $54.49M | $18.22M | $30.42M | (m) | (m) | $11.06M | $2.88M | (m) | 2.99× |
| 2026-03-31 | $64.30M | $17.83M | $39.54M | (m) | (m) | $12.21M | $3.89M | (m) | 3.61× |
| 2025-12-31 | $75.58M | $17.98M | $50.84M | (m) | (m) | $11.02M | $2.31M | (m) | 4.20× |
| 2025-09-30 | $56.05M | $16.98M | $29.71M | (m) | (m) | $11.56M | $2.37M | (m) | 3.30× |
| 2025-06-30 | $60.74M | $19.06M | $34.98M | (m) | (m) | $11.37M | $1.74M | $3.33M | 3.19× |
| 2025-03-31 | $69.75M | $16.54M | $42.83M | (m) | (m) | $13.53M | $4.00M | (m) | 4.22× |
| 2024-12-31 | $78.07M | $15.60M | $52.67M | (m) | (m) | $12.78M | $2.15M | (m) | 5.01× |
| 2024-09-30 | $44.13M | $16.86M | $17.30M | (m) | (m) | $13.60M | $2.48M | (m) | 2.62× |
| 2024-06-30 | $51.11M | $14.99M | $26.50M | (m) | (m) | $13.37M | $2.31M | (m) | 3.41× |
| 2024-03-31 | $62.62M | $15.18M | $37.14M | (m) | (m) | $13.60M | $3.36M | (m) | 4.13× |
| 2023-12-31 | $71.73M | $16.97M | $46.73M | (m) | (m) | $13.16M | $1.67M | (m) | 4.23× |
| 2023-09-30 | $82.25M | $15.33M | $58.20M | (m) | (m) | $14.32M | $3.09M | (m) | 5.36× |
| 2023-06-30 | $89.17M | $13.04M | $65.27M | (m) | (m) | $14.10M | $2.25M | (m) | 6.84× |
| 2023-03-31 | $53.50M | $14.41M | $30.12M | (m) | (m) | $15.11M | $5.22M | (m) | 3.71× |
| 2022-12-31 | $62.45M | $12.40M | $42.02M | (m) | (m) | $11.79M | $1.53M | (m) | 5.03× |
| 2022-09-30 | $73.95M | $15.21M | $54.23M | (m) | (m) | $12.14M | $4.86M | (m) | 4.86× |
| 2022-06-30 | $45.63M | $11.93M | $27.73M | (m) | (m) | $10.29M | $2.25M | (m) | 3.83× |
| 2022-03-31 | $50.33M | $12.29M | $33.02M | (m) | (m) | $10.27M | $5.70M | (m) | 4.10× |
| 2021-12-31 | $59.05M | $10.57M | $43.93M | (m) | (m) | $7.66M | $2.41M | (m) | 5.58× |
| 2021-09-30 | $65.54M | $9.38M | $53.64M | (m) | (m) | $6.27M | $2.33M | (m) | 6.99× |
| 2021-06-30 | $70.73M | $7.29M | $60.29M | (m) | (m) | $4.50M | $1.28M | (m) | 9.70× |
| 2021-03-31 | $75.20M | $5.64M | $65.83M | (m) | (m) | $4.69M | $965.00K | (m) | 13.34× |
| 2020-12-31 | $83.22M | $6.61M | $74.39M | (m) | (m) | $3.91M | $652.00K | (m) | 12.60× |
| 2020-09-30 | $89.02M | $5.34M | $81.47M | (m) | (m) | $4.04M | $976.00K | (m) | 16.65× |
| 2020-06-30 | $94.11M | $3.62M | $85.47M | (m) | (m) | $4.57M | $948.00K | (m) | 25.98× |
| 2020-03-31 | $55.31M | $4.23M | $41.41M | (m) | (m) | $4.80M | $1.39M | (m) | 13.07× |
| 2019-12-31 | $64.33M | $6.71M | $45.30M | (m) | (m) | $4.60M | $3.17M | (m) | 9.58× |
| 2019-09-30 | $17.62M | $6.31M | $10.70M | (m) | (m) | $4.27M | $1.70M | (m) | 2.79× |
| 2018-12-31 | $23.25M | $9.56M | $17.28M | (m) | (m) | $4.35M | $3.42M | (m) | 2.43× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |